[Platinum-based chemotherapy in renal transplant recipients with malignancies: a case report and review of literature].
Authors present a case of renal transplant recipient treated with a carboplatin-based chemotherapy for testicular embryonal carcinoma. The patient experienced severe treatment-related toxicity and died due to bone marrow aplasia 3 months after the diagnosis of cancer. The safety of platinum-based chemotherapy in renal transplant recipients is discussed with reference to the literature data.
Wójcik
J
J
Kliniki Onkologii i Radioterapii AM. jwojcik@amedec.amg.gda.pl
Bułło
B
B
Jassem
J
J
Rutkowski
B
B
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001855:Bone Marrow Diseases / Q000139:chemically induced*; D016190:Carboplatin / Q000009:adverse effects*; D018236:Carcinoma, Embryonal / Q000188:drug therapy*; D002648:Child; D017809:Fatal Outcome; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D013736:Testicular Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D016190:Carboplatin